Schizophrenia Trial, Recruiting NCT06624462 Sponsor: Bjorn H. Ebdrup Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT06624462
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a schizophrenia-related condition or bipolar disorder
  • You are currently taking antipsychotic medication
  • You are between 18 and 45 years old
  • You are legally able to make your own decisions
  • You are able to give your consent to take part in the trial
  • Your Body Mass Index (BMI — a measure of body weight relative to height) is 30 or above
  • OR your BMI is 27 or above AND you also have at least one of the following: high blood pressure, abnormal cholesterol or fat levels in your blood, sleep apnoea (where breathing stops briefly during sleep), or blood sugar levels that suggest prediabetes or diabetes
  • OR you have gained a noticeable amount of weight — either 5% or more of your body weight, or 5 cm or more around your waist — since you started taking antipsychotic medication

Who may not be able to join:

  • You have another serious physical or medical condition that the research team believes would make it unsafe for you to participate (confirm with trial site)
  • Your mental health condition is currently unstable, as assessed by the research team
  • You are currently dealing with severe problems with drug or alcohol misuse, as assessed by the research team
  • You are currently considered to be at serious risk of suicide

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bjorn H. Ebdrup, MD, Consultant,PhD, Professor,, Centre for Neuropsychiatric Schizophrenia Research, CNSR, Mental Health Centre Glostrup | University of Copenhagen

Phone: +4538640840

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Bjorn H. Ebdrup
Registry
ClinicalTrials.gov
Start date
10 October 2023
Est. completion
1 December 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Proportion of patients achieving a weight loss of ≥5% of initial body weight.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov